cancer

UCLA bioengineers have developed a revolutionary approach that brings together traditional drugs and nanotechnology-enhanced medications to create safer and more effective treatments.

Jillian Neuner raised $1,750 for UCLA research in honor of a friend battling Ewing's Sarcoma, one of the rarest forms of pediatric cancer.

Research at UCLA played key role in developing the treatment, which could signal a new strategy for arresting tumor growth and extending the time before cancer worsens.

The discovery by scientists at the UCLA Jonsson Comprehensive Cancer Center paves the way for the development of more effective patient-tailored therapies.

Less than a third of parents reported that their child wore a hat or sunglasses or attempted to seek shade when exposed to the sun.

A team led by researchers at the California NanoSystems Institute developed a new method for extracting and analyzing cancer cells circulating in patients’ blood.

UCLA study shows that combining palbociclib with letrozole effectively doubled the length of time women with estrogen receptor-positive breast cancer were on treatment without their cancer worsening.

UCLA researchers led by Aydogan Ozcan have developed a lens-free microscope that can be used to detect cancer with the same accuracy as larger and more expensive optical microscopes.

UCLA’s Edward Garon, the study’s principal investigator, says the drug offers new hope for people with lung cancer who often have few treatment options.

Unlike current surgical methods, the technique is minimally invasive with few side effects and does not require chemotherapy or radiation.

Logan Nobriga, a 10-year-old-boy who is battling cancer, was honored at a Bruins’ basketball game as the first “Kid Captain” selected by Mattel Children’s Hospital UCLA and the UCLA Men’s Basketball team.

National guidelines recommend that men in these cases should not be treated with radiation or surgery, since they are unlikely to live long enough to benefit from treatment.

The findings will help physicians determine the best treatment for patients most likely to respond to the drug and develop new combination treatments for melanoma and other cancers.

New research provides a better understanding of how osteonecrosis of the jaw progresses and could guide the development of therapeutic and preventive measures.

UCLA School of Dentistry researchers show that electric field-induced release and measurement is a reliable way to detect tumor-causing mutations that would be more cost-effective and efficient.

Michael Eselun, certified interfaith chaplain for the Simms/Mann UCLA Center for Integrative Oncology, explores "It could be worse," a common coping strategy for dealing with cancer.

UCLA study finds that a protein linked to neurological disorders is also associated with head and neck cancer in people who are infected with human papilloma virus.

Researchers suggest that practicing the ancient Chinese martial art could potentially lower the risk for cancer recurrence and other chronic diseases in cancer survivors.

UCLA research may lead to a simple saliva test to diagnose at an early stage diabetes and cancer, and perhaps neurological disorders and autoimmune diseases.

UCLA researchers have shown for the first time that the quality of diagnostic staging for biopsies of bladder cancer is directly linked with patients’ survival rates.

The findings could eventually lead to radiation and chemotherapy treatments that are more effective for people with cancer and other blood-related diseases.

Developed by UCLA’s Dr. Leonard Rome and Dr. Steven Dubinett, the treatment combines an immunotherapy agent with a drug delivery nanotechnology using nanoparticles called vaults.

A researcher at UCLA’s Jonsson Comprehensive Cancer Center helped develop the combination drug therapy that also lowers the risk of secondary cancers.

Utpal Banerjee, the Irving and Jean Stone Professor and chair of UCLA’s Department of Molecular, Cell and Developmental Biology in the UCLA College, will look at the important role of the fruit fly in helping scientists answer core questions about developmental biology.

Myra and David Mezquita have been struggling to pay for nursing care for their daughter Vicky, who is being treated for the second time for recurring living cancer. An organization founded by Westside teenagers has come to their aid.